{
    "Trade/Device Name(s)": [
        "Amphetamines II",
        "Amphetamines II Assay",
        "ONLINE Amphetamines II Assay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K093664",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083764",
        "K060645",
        "K080183"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "LAF"
    ],
    "Summary Letter Date": "July 2, 2010",
    "Summary Letter Received Date": "July 6, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Clean glass container",
        "Clean plastic container"
    ],
    "Instrument(s)/Platform(s)": [
        "COBAS INTEGRA systems",
        "COBAS INTEGRA 800 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Kinetic interaction of microparticles in solution (KIMS)"
    ],
    "Methodologies": [
        "Enzyme immunoassay",
        "Kinetic microparticle immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Amphetamines II Assay for COBAS INTEGRA analyzers to detect amphetamines and methamphetamines in urine by EIA/KIMS technology",
    "Indications for Use Summary": "In vitro diagnostic test for qualitative and semiquantitative detection of amphetamines and methamphetamines in human urine on COBAS INTEGRA systems at cutoff concentrations of 300, 500, and 1000 ng/mL when calibrated with d-methamphetamine; preliminary analytical test result requiring GC/MS confirmation.",
    "fda_folder": "Toxicology"
}